{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:42:28Z","timestamp":1788039748690,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ammonia is implicated in hepatic encephalopathy (HE) and prognostic in cirrhosis. Venous ammonia concentration, yielding similar correlation with HE grades as arterial, has become the preferred practise but comparative data are limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>To quantify effect of sampling site on ammonia concentration in healthy persons and patients with cirrhosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Ammonia concentrations were measured by arterial and femoral venous blood sampling in ten healthy men and ten male patients with cirrhosis before and during hyperammonaemia induced by ammonia infusion. Cubital vein samples were included during the infusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>At baseline, arterial-venous concentration gaps were similar (<jats:italic>p<\/jats:italic>\u2009=\u20090.15) in healthy persons [14 (10\u201319) and 8 (4\u201312) \u00b5mol\/L] and patients with cirrhosis [53 (32\u201374) and 40 (23\u201357) \u00b5mol\/L]. Ammonia infusion increased arterial-venous concentration gaps in both groups [115 (97\u2013133) and 61 (31\u201390) vs. 175 (123\u2013227) and 134 (65\u2013203) \u00b5mol\/L]. Mean ammonia concentration difference between groups during hyperammonaemia was 72 (42\u2013103) \u00b5mol\/L (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and independent of sampling site. Cubital and femoral vein concentrations were comparable (<jats:italic>p<\/jats:italic>\u2009=\u20090.26). In cirrhosis, calculated upper limit normal values (ULN) were comparable for arterial and venous blood at baseline [2.0 (1.2\u20132.8) and 2.1 (1.2\u20133.0), <jats:italic>p<\/jats:italic>\u2009=\u20090.74] and during hyperammonaemia [6.7 (4.7\u20138.7) and 6.2 (4.4\u2013 8.1), <jats:italic>p<\/jats:italic>\u2009=\u20090.44].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We found clinically meaningful intra-individual arterial-venous concentration gaps in both healthy persons and patients with cirrhosis at any ammonia concentration. Inter-group concentration differences after induced hyperammonaemia were relatively constant across sampling sites which supports clinical use of venous sampling. ULN-normalised ammonia concentrations were valid for both arterial and venous sampling.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11011-024-01442-4","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T09:22:53Z","timestamp":1732094573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Blood ammonia concentration measurement \u2013 effects of sampling site and cirrhosis during induced hyperammonaemia"],"prefix":"10.1007","volume":"40","author":[{"given":"Lars","family":"Djernes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1115-8308","authenticated-orcid":false,"given":"Peter Lykke","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"publisher","unstructured":"Bajaj JS, Bloom PP, Chung RT et al (2020) Variability and lability of Ammonia levels in healthy volunteers and patients with cirrhosis: implications for Trial Design and Clinical Practice. Am J Gastroenterol 115:783\u2013785. https:\/\/doi.org\/10.14309\/ajg.0000000000000384","DOI":"10.14309\/ajg.0000000000000384"},{"key":"1442_CR2","doi-asserted-by":"publisher","unstructured":"Balcar L, Krawanja J, Scheiner B et al (2023) Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease. JHEP Rep 5:100682. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100682","DOI":"10.1016\/j.jhepr.2023.100682"},{"key":"1442_CR3","doi-asserted-by":"publisher","unstructured":"Ballester MP, Tranah TH, Balcar L et al (2023) Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis. J Hepatol 79:967\u2013976. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.022","DOI":"10.1016\/j.jhep.2023.05.022"},{"key":"1442_CR4","doi-asserted-by":"publisher","unstructured":"Dam G, Keiding S, Munk OL et al (2011) Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. Am J Physiol Gastrointest Liver Physiol 301:G269\u2013277. https:\/\/doi.org\/10.1152\/ajpgi.00062.2011","DOI":"10.1152\/ajpgi.00062.2011"},{"key":"1442_CR5","doi-asserted-by":"publisher","unstructured":"Eriksen PL, Djernes L, Vilstrup H, Ott P (2023) Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments. J Hepatol 79:340\u2013348. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.042","DOI":"10.1016\/j.jhep.2023.03.042"},{"key":"1442_CR6","doi-asserted-by":"publisher","unstructured":"Eriksson LS, Broberg S, Bj\u00f6rkman O, Wahren J (1985) Ammonia metabolism during exercise in man. Clin Physiol 5:325\u2013336. https:\/\/doi.org\/10.1111\/j.1475-097x.1985.tb00753.x","DOI":"10.1111\/j.1475-097x.1985.tb00753.x"},{"key":"1442_CR7","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver(2022) EASL Clinical Practice guidelines on the management of hepatic encephalopathy. J Hepatol 77:807\u2013824. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.001","DOI":"10.1016\/j.jhep.2022.06.001"},{"key":"1442_CR8","doi-asserted-by":"publisher","unstructured":"Haj M, Rockey DC (2020) Ammonia levels do not Guide Clinical Management of patients with hepatic Encephalopathy caused by cirrhosis. Am J Gastroenterol 115:723\u2013728. https:\/\/doi.org\/10.14309\/ajg.0000000000000343","DOI":"10.14309\/ajg.0000000000000343"},{"key":"1442_CR9","doi-asserted-by":"publisher","unstructured":"Huizenga JR, Gips CH, Tangerman A (1996) The contribution of various organs to Ammonia formation: a review of factors determining the arterial Ammonia concentration. Ann Clin Biochem 33:23\u201330. https:\/\/doi.org\/10.1177\/000456329603300103","DOI":"10.1177\/000456329603300103"},{"key":"1442_CR10","doi-asserted-by":"publisher","unstructured":"Lattanzi B, D\u2019Ambrosio D, Merli M (2019) Hepatic encephalopathy and Sarcopenia: two faces of the same metabolic alteration. J Clin Exp Hepatol 9:125\u2013130. https:\/\/doi.org\/10.1016\/j.jceh.2018.04.007","DOI":"10.1016\/j.jceh.2018.04.007"},{"key":"1442_CR11","doi-asserted-by":"publisher","unstructured":"Lockwood AH (2004) Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 19:345\u2013349. https:\/\/doi.org\/10.1023\/b:mebr.0000043980.74574.eb","DOI":"10.1023\/b:mebr.0000043980.74574.eb"},{"key":"1442_CR12","doi-asserted-by":"crossref","unstructured":"Manjunath R, NH N, Bhardwaj V (2014) Clinical co relation between arterial versus venous ammonia levels in hepatic encephlopathy in cirrhosis of liver. J Evol Med Dent Sci 3:5322","DOI":"10.14260\/jemds\/2014\/2594"},{"key":"1442_CR13","doi-asserted-by":"publisher","unstructured":"Nicolao F, Efrati C, Masini A et al (2003) Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 38:441\u2013446. https:\/\/doi.org\/10.1016\/S0168-8278(02)00436-1","DOI":"10.1016\/S0168-8278(02)00436-1"},{"key":"1442_CR14","doi-asserted-by":"publisher","unstructured":"Ong JP, Aggarwal A, Krieger D et al (2003) Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 114:188\u2013193. https:\/\/doi.org\/10.1016\/s0002-9343(02)01477-8","DOI":"10.1016\/s0002-9343(02)01477-8"},{"key":"1442_CR15","unstructured":"Seligson D, Hirahara K (1957) The measurement of ammonia in whole blood, erythrocytes, and plasma. J Lab Clin Med 49:962\u2013974"},{"key":"1442_CR16","doi-asserted-by":"publisher","unstructured":"Shalimar null, Sheikh MF, Mookerjee RP et al (2019) Prognostic role of Ammonia in patients with cirrhosis. Hepatology 70:982\u2013994. https:\/\/doi.org\/10.1002\/hep.30534","DOI":"10.1002\/hep.30534"},{"key":"1442_CR17","doi-asserted-by":"publisher","unstructured":"Stahl J (1963) Studies of the blood ammonia in liver disease: its diagnostic, prognostic, and therapeutic significance. Ann Intern Med 58:1. https:\/\/doi.org\/10.7326\/0003-4819-58-1-1","DOI":"10.7326\/0003-4819-58-1-1"},{"key":"1442_CR18","doi-asserted-by":"publisher","unstructured":"Tapper EB, Rahimi RS (2020) Low-value levels: Ammonia Testing does not improve the outcomes of overt hepatic encephalopathy. Am J Gastroenterol 115:685\u2013686. https:\/\/doi.org\/10.14309\/ajg.0000000000000454","DOI":"10.14309\/ajg.0000000000000454"},{"key":"1442_CR19","doi-asserted-by":"publisher","unstructured":"Tranah TH, Ballester M-P, Carbonell-Asins JA et al (2022) Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. J Hepatol 77:1554\u20131563. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.014","DOI":"10.1016\/j.jhep.2022.07.014"},{"key":"1442_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0016-5085(19)35245-X","volume":"39","author":"MP Tyor","year":"1960","unstructured":"Tyor MP, Owen EE, Berry JN, Flanagan JF (1960) The relative role of extremity, liver, and kidney as ammonia receivers and donors in patients with liver disease. Gastroenterology 39:420\u2013424","journal-title":"Gastroenterology"},{"key":"1442_CR21","doi-asserted-by":"publisher","unstructured":"Vierling JM, Mokhtarani M, Brown RS et al (2016) Fasting blood Ammonia predicts risk and frequency of hepatic encephalopathy episodes in patients with cirrhosis.Clin Gastroenterol Hepatol 14:903\u2013906e1. https:\/\/doi.org\/10.1016\/j.cgh.2015.11.018","DOI":"10.1016\/j.cgh.2015.11.018"},{"key":"1442_CR22","doi-asserted-by":"publisher","unstructured":"Warter JM, Brandt C, Marescaux C et al (1983) The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 33:1136\u20131140. https:\/\/doi.org\/10.1212\/wnl.33.9.1136","DOI":"10.1212\/wnl.33.9.1136"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-024-01442-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-024-01442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:56:06Z","timestamp":1740549366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-024-01442-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1007\/s11011-024-01442-4","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study conformed to the ethical guidelines of the Declaration of Helsinki and Danish and European Union legislation on data protection. The protocol was approved by the Central Denmark Region Committees on Health Research Ethics (110-72-165-19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"21"}}